Results 71 to 80 of about 10,629 (179)

Post-inflammatory Hyperpigmentation in Skin of Color: Emerging Therapies and Treatment Algorithms. [PDF]

open access: yesCureus
Persson C   +7 more
europepmc   +1 more source

Preparation and Evaluation of Radiolabeled Porphyrin-Functionalized Lipid Nanodroplets for Cancer Theranostics. [PDF]

open access: yesMolecules
Ramzi NIB   +9 more
europepmc   +1 more source

Inhibition of peripubertal sheep mammary gland development by cysteamine through reducing progesterone and growth factor production

open access: yes, 2017
Cysteamine has been used for treating cystinosis for many years, and furthermore it has also been used as a therapeutic agent for different diseases including Huntington's disease, Parkinson's disease (PD), nonalcoholic fatty liver disease, malaria ...
Zhang, P.   +10 more
core  

Inhibition of Low-Density Lipoprotein Oxidation by Cysteamine, Cystamine, Cysteine and Cystine at Lysosomal pH and pH 7.4. [PDF]

open access: yesAntioxidants (Basel)
Parkes EJ   +8 more
europepmc   +1 more source

Negligible urinary cysteamine loss in cystinosis patients with Fanconi syndrome.

open access: yes, 2002
Cystinosis is an inborn error of lysosomal cystine transporter, resulting in cystine accumulation in lysosomes of all cells. Renal Fanconi syndrome is an early sign of kidney involvement in cystinosis patients.
Monnens, L.A.H.   +3 more
core  

Home - About - Disclaimer - Privacy